Company Bio (50 Words)
Evosep aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. Making sample preparation and separation before MS analysis 10 times faster and 100 times more robust will enable truly large cohort studies for biomarker validation and provide the foundation for precision medicine.
Company Bio (25 Words)
Evosep aims to make clinical proteomics 100 times more robust and 10 times faster by radically innovating sample preparation and separation prior to MS analysis.
Product images for presentations
Download this presentation for ready-to-use descriptions about Evosep and our technology and get images to use in presentations. Download here
High-res images for download
Evosep PRESS coverage
Here you can find the latest Evosep press coverage including press releases and collaborations.
(March 2023) Evosep and Resyn Biosciences partner to integrate their technologies into new clinical proteomics solutions
ReSyn Biosciences and Evosep have recently demonstrated several joint solutions thatintegrate automated sample purification with liquid chromatography coupled mass spectrometry.
(March 2023) Evosep ESTABLISHES CENTER OF EXCELLENCE FOR HIGH-THROUGHPUT AND STANDARDIZED PROTEOMICS
Evosep Biolabs will partner with key players in the proteomics area, execute end-to-end workflows on customer projects, remove barriers to entry by acting as an external, expert lab partner, as well as providing extra, ad-hoc capacity to established organizations.
(January 2023) EVOSEP RECEIVES STRATEGIC INVESTMENT FROM NOVO HOLDINGS A/S TO ACCELERATE ITS EFFORT ON CLINICAL PROTEOMICS
Odense, Denmark – Evosep Aps (January 9, 2023) – Evosep today announced that Novo Holdings A/S has become a minority shareholder in Evosep Aps with a US$ 40m investment to further Evosep’s technology and application portfolio for clinical proteomics.
(December 2022) Evosep adds automation to its standardized platform
Cancun, Mexico – HUPO 2022. Today, at the 21st Human Proteome Organization World Congress, Evosep launches new separation methods and a protocol for automated loading of Evotips enabling end-to-end high throughput proteomics workflows.
(June 2022) Evosep One enables robust, high throughput, single cell proteomics.
Minneapolis – ASMS 2022. At the 68th Conference on Mass Spectrometry and Allied Topics, Evosep introduces new methods for standardization of high throughput single cell proteomics, higher throughput clinical analysis, and improved diabetes monitoring.
(April 2022) Evosep introduces new Evotip Pure for improved performance, especially for high sensitivity workflows
Leipzig – EuPA 2022. Today, at the XIV Annual Congress of the European Proteomic Association, Evosep introduces a new and vastly improved generation of Evotips, called Evotip Pure™.
(February 2022) MRM Proteomics, Inc. and AgilenT Technologies, Inc.: A Collaboration for Progress
The Evosep One combines with the new Agilent 6495C and kits from MRM Proteomics Inc. offering complete solutions for quantitative protein analysis.
(January 2022) Evosep and ZefSci partner to
increase and improve US service coverage
Evosep Aps and Zef Scientific, Inc. announce that they have entered a partnership to increase and improve the US service coverage for the growing Evosep One install base. The agreement covers all service aspects from installations over warranty provision, preventive maintenance, and troubleshooting visits.
(november 2021) SCIEX and Evosep will collaborate to provide robust, high-throughput proteomics workflows
SCIEX and Evosep announce an agreement to co-market products together to improve robust, high-throughput proteomics workflows for precision medicine. Download PDF version
(MAY 2021) Bruker Launches timsTOF SCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth
The timsTOF SCP is the culmination of a collaboration with the laboratory of Professor Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried, Germany, and with Evosep on new Whisper methods at ultra-low flow rates of ~100 nL/min.
(March 2021) Bruker Announces New Results in Deep, Unbiased Plasma Proteomics, PaSER 1.1 Software US HUPO 2021
At US HUPO 2021, Bruker Daltonics published a PR, focusing on high throughput application (most of them equipped with Evosep One front-ends).
(October 2020) Bruker Introduces PaSER™ Software for ‘Run and Done’ 4D- ProteomicsTM and TIMS/PASEF Method Wins HUPO 2020 Award
At the HUPO CONNECT conference, Bruker announces further progress to develop ultra-high sensitivity solutions for single cell proteomics using Evosep One and their timsTOF Pro powered by PASEF.
(JUNE 2020) Evosep and Agilent Technologies will collaborate to further improve their robus, high-throughput workflows for proteomics
At the ASMS 2020 Reboot, Evosep and Agilent Technologies announced their joint efforts in clinical proteomics.
(June 2020) Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems and Software During Virtual ASMS Event
Thermo Fisher Scientific will provide online programming and virtual exhibits to introduce scientists to a number of new products that build on its leading Orbitrap platform and expand research applications.
(June 2019) Thermo Fisher Scientific Announces Collaboration to Revolutionize Profiling of Large Plasma Sample Cohorts in Protein-based Clinical Research Studies
ASMS 2019 – Thermo Fisher Scientific and Evosep have entered into a collaboration to develop high-throughput clinical research proteomics workflows for profiling large plasma sample cohorts for proteomics, translational research and pharmaceutical applications.
(March 2019) Bruker Announces Progress in Advanced Methods and Software Tools for 4D High-Throughput and Ultra-High Sensitivity Proteomics
At the 15th Annual Conference of the US Human Proteome Organization, Bruker announces further progress in high-sensitivity, high-throughput plasma-proteomics using the timsTOF Pro mass spectrometer connected to an Evosep One low-flow chromatography system.
(October 2018) HUPO Moving in Translational, Clinical Direction as HPP Project Approaches Goal
Biognosys and Evosep jointly announced a high-throughput workflow for clinical plasma proteomics that combines Biognosys’ PQ500 plasma protein panel, which quantifies 500 proteins using DIA mass spec, with the Evosep One liquid chromatography system.
(October 2018) BRUKER ANNOUNCES BREAKTHROUGH PROTEOMICS AND LIPIDOMICS WORKFLOW FOR ADVANCES FOR THE TIMSTOF PRO AT HUPO 2018
With the release of a Bruker plug-in to control the Evosep One LC system, Bruker and Evosep now announce a co-selling agreement, which enables Bruker to sell, support and service a complete solution for proteomics labs requiring extreme throughput, sensitivity and robustness.
(October 2018) BIOGNOSYS AND EVOSEP PROMOTE JOINED ROBUST, HIGH-THROUGHPUT WORKFLOWS FOR CLINICAL PLASMA PROTEOMICS
At the 17th Human Proteome Organization World Congress, Biognosys and Evosep jointly promote a robust, high-throughput workflow for clinical research proteomics.
(August 2018) Evosep LC System Enables Mass Spec Throughput of 200 Samples per Day
Researchers from the Max Planck Institute of Biochemistry, University of Copenhagen, and liquid chromatography firm Evosep Biosystems have developed a mass spec-based proteomics workflow capable of running more than 200 samples per day.
(June 2018) Thermo Scientific and Evosep join hands to develop robust, high-throughput workflows for clinical proteomics
At the 66th Conference on Mass Spectrometry and Allied Topics, Thermo Scientific and Evosep announced a joint effort to develop and promote robust, high-throughput workflows for clinical proteomics
(June 2018) Bruker Introduces scimaX™ MRMS for Novel Phenomics Workflows, and Further Enhances the timsTOF™ Pro for PASEF Proteomics at ASMS
In their press release at the 66th ASMS Conference, Bruker announces full integration with the Evosep One separation device with Bruker’s Hystar LC/MS control for high-throughput clinical proteomics of up to 200 samples per day. This novel combination delivers superb sensitivity (50 ng HeLa) and high throughput for LFQ of ~1,200 proteins in only ~5 minutes.
(June 2018) ASMS recap by genome web
To further increase throughput, Mann and his colleagues combined the timsTOF Pro with the Evosep One LC system, which uses a preformed gradient to improve assay robustness and cut downtime between injections.
(June 2018) journal of integrated omics: shotgun proteomics: where do we stand now?
Making a sample ready for shoutgun proteomics analysis has always been a timeconsuming operation. However, new techniological advances in chromatpgraphy are called to change the panorama dramatically.
(March 2018) Bruker and Evosep Announce New Integrated Clinical Research Proteomics Solution to Quantify Over a Thousand Proteins in Five Minutes
At the 2018 US HUPO Conference, Bruker and Evosep announce that they have executed a co-development and co-marketing agreement for the Evosep One chromatography system to work seamlessly with Bruker’s timsTOF Pro ultra-high resolution quadrupole time of flight mass spectrometer.
(February 2018) Bruker Highlights Innovative Analytical Solutions and Systems at Pittcon 2018
At Pittcon 2018, Bruker this week will highlight various innovative analytical systems and new high-value solutions – Bruker’s revolutionary timsTOF Pro mass spectrometer for high sensitivity proteomics can now be integrated with the Evosep One separation device for high-throughput clinical proteomics.
(September 2017) Evosep Introduces A Novel Separation Solution Designed for Clinical Omics at HUPO 2017
Today, the Evosep One is introduced, a novel separation solution designed for fast and robust separation of omics samples in large clinical cohort studies (primarily proteomics and metabolomics).
Did you not find what you were looking for?
Do not hesistate to contact us with any questions or comments you might have at firstname.lastname@example.org.
We are here to help and answer any question you might have. Please select a topic below related to your inquiry. If you did not find what you were looking for, fill in our contact form and we will get back to you as soon as possible.